Cardiovascular diseases are an important cause of morbidity and mortality worldwide and the global burden of these diseases continues to grow. Therefore new therapies are urgently needed. The role of protein kinases in disease, including cardiac disease, is long recognized, making kinases important therapeutic targets. We here review the knowledge gathered in the last decade about troponin I-interacting kinase (TNNI3K), a kinase with cardiac-restricted expression that has been implicated in various cardiac phenotypes and diseases including heart failure, cardiomyopathy, ischemia/reperfusion injury and conduction of the cardiac electrical impulse. (C) 2015 Elsevier Ltd. All rights reserved.
机构:
Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA
Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USANIH, Natl Biotechnol Ctr, Natl Lib Med, Bethesda, MD 20894 USA
机构:
Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA
Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USANIH, Natl Biotechnol Ctr, Natl Lib Med, Bethesda, MD 20894 USA